PALVELLA THERAPEUTICS INC (PVLA) Forecast, Price Target & Analyst Ratings

NASDAQ:PVLA • US6979471090

Current stock price

112.885 USD
+0.52 (+0.46%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for PALVELLA THERAPEUTICS INC (PVLA).

Forecast Snapshot

Consensus Price Target

Price Target
$224.97
+ 99.29% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
Mar 31, 2026
Period
Q4 / 2025
EPS Estimate
-$0.93
Revenue Estimate
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
84.55%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$224.97
Upside
+ 99.29%
From current price of $112.89 to mean target of $224.97, Based on 22 analyst forecasts
Low
$194.93
Median
$216.75
High
$280.35

Price Target Revisions

1 Month
16.93%
3 Months
26.04%

Price Target Summary

22 Wall Street analysts provided a forecast for the next 12 months for PVLA. The average price target is 224.97 USD. This implies a price increase of 99.29% is expected in the next year compared to the current price of 112.885.
The average price target has been revised upward by 26.04% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

PVLA Current Analyst RatingPVLA Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 5 10

Analyst Ratings History

PVLA Historical Analyst RatingsPVLA Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10 15 20

Analyst Ratings Consensus

ChartMill Buy Consensus
84.55%
PVLA was analyzed by 22 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about PVLA.
In the previous month the buy percentage consensus was at a similar level.
PVLA was analyzed by 22 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-03-24HC Wainwright & Co.Maintains Buy -> Buy
2026-03-16Chardan CapitalMaintains Buy -> Buy
2026-02-25MizuhoMaintains Outperform -> Outperform
2026-02-25BTIGMaintains Buy -> Buy
2026-02-24Chardan CapitalMaintains Buy -> Buy
2026-02-24HC Wainwright & Co.Maintains Buy -> Buy
2026-01-29BTIGReiterate Buy -> Buy
2026-01-16BTIGReiterate Buy -> Buy
2026-01-07MizuhoInitiate Outperform
2025-12-16TD CowenMaintains Buy -> Buy
2025-12-16Chardan CapitalMaintains Buy -> Buy
2025-12-16Truist SecuritiesMaintains Buy -> Buy
2025-12-16Canaccord GenuityMaintains Buy -> Buy
2025-12-15BTIGMaintains Buy -> Buy
2025-12-15HC Wainwright & Co.Maintains Buy -> Buy
2025-12-05Clear StreetInitiate Buy
2025-12-05BTIGInitiate Buy
2025-12-04Craig-HallumInitiate Buy
2025-11-24StifelMaintains Buy -> Buy
2025-11-19Raymond JamesUpgrade Outperform -> Strong Buy
2025-11-13Chardan CapitalMaintains Buy -> Buy
2025-11-13Canaccord GenuityMaintains Buy -> Buy
2025-11-10Truist SecuritiesMaintains Buy -> Buy
2025-11-07Chardan CapitalMaintains Buy -> Buy
2025-11-06TD CowenMaintains Buy -> Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
Mar 31, 2026
Period
Q4 / 2025
EPS Estimate
-$0.93
Revenue Estimate
Revenue Q2Q
N/A
EPS Q2Q
65.83%
Number of Analysts
18

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
0.07%
EPS (3 Months)
-1.49%

Next Earnings Summary

PVLA is expected to report earnings on 3/31/2026. The consensus EPS estimate for the next earnings is -0.93 USD and the consensus revenue estimate is 0 USD.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2025 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
PVLA revenue by date.PVLA revenue by date.
31.418M
7.14%		25.902M
-17.56%		42.81M
65.28%		15.004K
-100.00%		27.203K25.379M
93,193.49%		88.593M
249.08%		326.21M
268.21%		696.78M
113.60%		1.025B
47.11%		1.222B
19.22%		1.546B
26.51%
EBITDA
YoY % growth
PVLA ebitda by date.PVLA ebitda by date.
-49.372M
-56.19%		-40.704M
17.56%		-13.94M
65.75%		-15.463M
-10.93%		-38.792M
-150.86%		-51.756M
-33.42%		-53.665M
-3.69%		-46.528M
13.30%		253.13M
644.03%		741.82M
193.06%		1.225B
65.13%		1.795B
46.53%		2.423B
34.99%
EBIT
YoY % growth
PVLA ebit by date.PVLA ebit by date.
-51.831M
-52.80%		-43.474M
16.12%		-15.844M
63.56%		-16.733M
11.64%		-38.819M
-177.28%		-54.499M
-40.39%		-83.023M
-52.34%		-54.129M
34.80%		128.36M
337.14%		425.04M
231.13%		671.28M
57.93%		788.5M
17.46%		1.052B
33.42%
Operating Margin
PVLA operating margin by date.PVLA operating margin by date.
-164.97%-167.84%-37.01%-111,524.13%N/A-200,339.07%-327.13%-61.10%39.35%61.00%65.49%64.53%68.05%
EPS
YoY % growth
PVLA eps by date.PVLA eps by date.
-55.37
-1.79%		-36.00
34.99%		N/A
99.01%		-3.06
-758.09%		-3.59
-17.14%		-3.95
-10.20%		-5.11
-29.35%		-3.16
38.21%		8.18
358.72%		25.27
209.03%		38.03
50.50%		39.58
4.06%		50.43
27.42%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth		-0.93
65.83%		-0.85
-15.41%		-0.87
-0.71%		-1.01
2.05%		-1.13
-21.41%		-1.60
-86.92%		-1.86
-114.94%		-2.17
-114.84%		-1.55
-37.39%
Revenue
Q2Q % growth		20.4K20.4K1.785M
8,650.00%		15.517M
75,963.73%
EBITDA
Q2Q % growth		-10.948M
-97.62%		-11.011M
-54.61%		-12.071M
-47.08%		-13.681M
-39.15%		-14.993M
-36.95%		N/AN/AN/AN/A
EBIT
Q2Q % growth		-10.908M
-637.02%		-11.637M
-47.85%		-12.441M
-34.49%		-14.959M
-46.99%		-16.961M
-55.49%		-22.593M
-94.14%		-26.214M
-110.71%		-30.345M
-102.85%		-21.715M
-28.03%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

PVLA Yearly Revenue VS EstimatesPVLA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2026 2027 2028 2029 2030 2031 2032 2033 500M 1B 1.5B
PVLA Yearly EPS VS EstimatesPVLA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 20 -20 40 -40 -60

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
-18.63%
EPS Next 5 Year
36.10%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
1,091.48%
Revenue Next 5 Year
636.98%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
-47.47%
EBIT Next 5 Year
76.50%
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

PALVELLA THERAPEUTICS INC / PVLA Forecast FAQ

What is the average price target for PALVELLA THERAPEUTICS INC (PVLA) stock?

22 analysts have analysed PVLA and the average price target is 224.97 USD. This implies a price increase of 99.29% is expected in the next year compared to the current price of 112.885.

What is the next earnings date for PVLA stock?

PALVELLA THERAPEUTICS INC (PVLA) will report earnings on 2026-03-31, before the market open.

What are the consensus estimates for PALVELLA THERAPEUTICS INC (PVLA) next earnings?

The consensus EPS estimate for the next earnings of PALVELLA THERAPEUTICS INC (PVLA) is -0.93 USD and the consensus revenue estimate is 0 USD.

How many analysts have analysed PALVELLA THERAPEUTICS INC (PVLA)?

The number of analysts covering PALVELLA THERAPEUTICS INC (PVLA) is 22.